Effect of modulators of tyrosine kinase activity on agonist-induced contraction in the rat pulmonary vascular smooth muscle

Pulmonary Pharmacology

Volumn 9, Issue 3, 1996, Pages 189-195

  Savineau, J P ^a   Gonzalez De La Fuente, P ^a   Marthan, R ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Genistein; Phenylarsine oxide; Pulmonary artery; Smooth muscle contraction; Thapsigargin

Indexed keywords

ANGIOTENSIN; ARSENOSOBENZENE; BETA ESCIN; CALCIUM ION; DANTROLENE; GENISTEIN; NORADRENALIN; POTASSIUM CHLORIDE; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; THAPSIGARGIN; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; LUNG CIRCULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0030174985     PISSN: 09520600     EISSN: None     Source Type: Journal    
DOI: 10.1006/pulp.1996.0022     Document Type: Article

References (28)

1. 1. Putney J W, Bird G St J. The inositol phosphate-calcium signaling system in non-excitable cells. Endocrine Rev 1993; 14: 610-631.
2. 2+ influx: how many mechanisms for how many channels? Trends Pharmacol Sci 1994; 15: 77-83.
3. 2+ entry by tyrosine kinase inhibitors. J Biol Chem 1993; 268: 9945-9948.
4. 2+ entry and protein-tyrosine phosphylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5 dihydroxycinnamate in fura-2-loaded human platelets. J Biol Chem 1993; 268: 18151-18156.
5. 5. Fletcher M C, Samelson L E, June C H. Complex effects of phenylarsine oxide in T cells. J Biol Chem 1993; 268: 23697-23703.
6. 6. Somlyo A P, Somlyo A V. Signal transduction and regulation in smooth muscle. Nature 1994; 372: 231-236.
7. 2+ entry in vascular smooth cells: nicardipine-sensitive and -insensitive pathways. Am J Physiol 1992; 262: C1258-1265.
8. ++ pool in vascular smooth muscle. J Pharmacol Exp Ther 1991; 258: 1105-1112.
9. 2+ pump blockers: thapsigargin and cyclopiazonic acid. Pflügers Arch 1995; 429: 617-624.
10. 10. Di Salvo J, Steusloff A, Semenchuck L, Satoh S, Kolquist K, Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem Biophys Res Commun 1993; 190: 968-974.
11. 11. Hollenberg M D. Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci 1994; 15: 108-114.
12. 12. Laniyonu A, Saifeddine M, Ahmad S, Hollenberg M D. Regulation of vascular and gastric smooth muscle contractility by pervanadate. Br J Pharmacol 1994; 113: 403-410.
13. 13. Savineau J P, Marthan R. Effect of cromakalim on KCl-Noradrenaline-and angiotensin II-induced contraction in the rat pulmonary artery. Pulm Pharmacol 1993; 6: 41-48.
14. 14. Savineau J P, Gonzalez De La Fuente P, Marthan R. Effect of vascular smooth muscle relaxants on the protein kinase C-mediated contraction in the rat pulmonary artery. Eur J Pharmacol 1993; 249: 191-198.
15. 2+ channels in the smooth muscle cell membrane of rabbit small intestine. Pflügers Arch 1987; 408: 552-557.
16. 561ck by the CD45 phosphotyrosine phosphatase. Proc Natl Acad Sci USA 1989; 86: 6302-6306.
17. 17. Mustelin T, Coggeshall K M, Altman A. T-cell antigen receptor-mediated activation of phospholipase C requires tyrosine phosphorylation. Science 1990; 247: 1584-1587.
18. 18. Garcia-Morales P, Minami Y, Luong E, Klausner R D, Samelson L E. Tyrosine phosphorylation in T cells is regulated by phosphatase activity: studies with phenylarsine oxide. Proc Natl Acad Sci USA 1990; 87: 9255-9259.
19. 19. Liao K, Hoffman R D, Lane M D. Phosphotyrosyl turnover in insulin signaling. J Biol Chem 1991; 266: 6544-6553.
20. 60c-SRC kinase activity in extracts from vascular smooth muscle. J Biol Chem 1989; 264: 10773-10778.
21. 21. Tsuda T, Kawahara Y, Shii K, Koïde M, Ishida Y, Yokohama M. Vasoconstrictor induced protein-tyrosine phosphorylation in cultured vascular smooth muscle cells. FEES Lett 1991; 285: 44-48.
22. 22. Molloy C J, Taylor D S, Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cell. J Biol Chem 1993; 268: 7338-7345.
23. 23. Marrero M B, Paxton W G, Duff J L, Berk B C, Bernstein K E. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-γ1 in vascular smooth muscle cells. J Biol Chem 1994; 269: 10935-10939.
24. 24. Ohta T, Ito S, Ohga A. Inhibitory action of dantrolene on Ca-induced Ca-release from sarcoplasmic reticulum in guinea-pig skeletal muscle. Eur J Pharmacol 1990; 178: 11-19.
25. 2+ mobilization from intracellular pool(s), using dantrolene, in the glycogenolytic action of α-adrenergic stimulation in perfused rat liver. Biochim Biophys Acta 1987; 927: 229-234.
26. 2+ stores by specific inhibition of the endoplasmic reticulum Ca-ATPase. Proc Natl Acad Sci USA 1990; 87: 2466-2470.
27. 27. Vostal J, Jackson W L, Shulman N R. Cytosolic and stored calcium antagonistically control tyrosine phosphorylation of specific platelet proteins. J Biol Chem 1991; 266: 16911-16916.
28. 2+ influx by a tyrosine kinase-dependent pathway. J Biol Chem 1994; 269: 26239-26242.